Benefits and risks of HPV testing in cervical cancer screening

The Lancet Oncology

Volumn 11, Issue 3, 2010, Pages 214-215

  Castle, Philip E ^a   Katki, Hormuzd A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; COLPOSCOPY; CYTOLOGY; DIAGNOSTIC TEST; DNA DETERMINATION; ELECTROSURGERY; FOLLOW UP; GENOTYPE; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VERRUCA VULGARIS; WART VIRUS;

CYTOGENETIC ANALYSIS; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 77649179937     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70385-7     Document Type: Letter

References (8)

1. Ronco G., Giorgi-Rossi P., Carozzi F., et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol (2010) 10.1016/S1470-2045(09)70360-2 published online Jan 19.
2. Sankaranarayanan R., Nene B.M., Shastri S.S., et al. HPV screening for cervical cancer in rural India. N Engl J Med 360 (2009) 1385-1394
3. Sasieni P., Castanon A., and Cuzick J. Screening and adenocarcinoma of the cervix. Int J Cancer 125 (2009) 525-529
4. Kitchener H.C., Almonte M., Thomson C., et al. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol 10 (2009) 672-682
5. Sasieni P., Castle P.E., and Cuzick J. Further analysis of the ARTISTIC trial. Lancet Oncol 10 (2009) 841-842
6. McCredie M.R., Sharples K.J., Paul C., et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 9 (2008) 425-434
7. Arbyn M., Kyrgiou M., Simoens C., et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ (2008) 10.1136/bmj.a1284.:a1284 published online Sept 18.
8. Katki H.A., Wacholder S., Solomon D., Castle P.E., and Schiffman M. Risk estimation for the next generation of prevention programmes for cervical cancer. Lancet Oncol 10 (2009) 1022-1023